Time-Driven Activity-Based Costing in Oncology: A Step in the Right Direction

The standard of care for locally advanced cervical cancer is the combination of chemotherapy, external beam radiation therapy (EBRT), and brachytherapy. The integration of magnetic resonance imaging–based planning and delivery for brachytherapy has resulted in local control rates of 80-90%, with a reduced risk of grade 3 morbidities (1). Despite these excellent results, a surprising number of patients with cervical cancer do not receive brachytherapy in favor of intensity modulated radiation therapy (IMRT) or stereotactic body radiation therapy boosts, resulting in inferior survival outcomes (2, 3).

http://ift.tt/2AuPWKH